NCT00335738
Clinical Trial Information
Trial Number: NCT00335738 (ClinicalTrials.gov)
Disease Type:
- Eye Neoplasm - Retinoblastoma
Trial Title:
A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
Study ID:
ARET0332
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00335738-D2 | NCT00335738-D2 is one of 2 data submissions associated with PubMed ID 31539297. This dataset provides the information for the specific toxicities that occurred during protocol therapy. There is one row per patient/toxicity term. Each row has the maximum grade of the particular toxicity term observed during the patient’s protocol treatment. |
| NCT00335738-D1 | NCT00335738-D1 is one of 2 data submissions associated with PubMed ID 31539297. There is one row for each patient enrolled. The dataset provides the information of consort flow of patient enrollment, baseline characteristics, central pathology review results, and outcome data on ARET0332 as reported in the manuscript. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®